Opioids - Articles - Page 2 | CARLAT PUBLISHING

A Single Prescriber Reduces Risk of Overdose in Patients on Opioid and Benzodiazepine

September 25, 2022

Kamron Fariba, MD. Dr. Fariba, author of this educational activity, has no relevant financial relationship(s) with ineligible companies to disclose.

This large study suggests a practical solution to reduce mortality in patients who are taking both benzodiazepines and opioids.

Drug Overdoses in the US: Trends and Prevention Strategies

November 5, 2021

Joshua Sharfstein, MD

Joshua Sharfstein, MD

Professor of the Practice of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.

Dr. Sharfstein has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Increases in drug overdose mortality continues unabated around the country driven by widespread availability of illicit fentanyl and methamphetamines. Dr. Sharfstein provides context to these concerning trends and discusses prevention and harm reduction strategies clinicians can implement for their patients.

An Unexpected Opioid: Loperamide Misuse

May 21, 2021

Mara Storto, MD. and Deepti Anbarasan, MD.

Mara Storto, MD. Psychiatric Resident, Psychiatry Residency Training Program, New York University Langone Health, New York, NY. Deepti Anbarasan, MD. Clinical Assistant Professor of Psychiatry, New York University, New York, NY. Dr. Storto and Dr. Anbarasan have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

We normally think of loperamide as an over-the-counter drug with a good safety profile. And it is, but only when used as directed. Recreational misuse of loperamide is on the rise with some dangerous collateral effects.

The Other Pandemic

March 19, 2021

Predictions that overdose mortality would worsen during the COVID-19 pandemic have unfortunately proven accurate. Recent data outlined in an alert by the CDC show that rates of overdose deaths from opioids and stimulants have accelerated at an alarming rate.

CLINICAL UPDATE

Perioperative Pain Management in Opioid Use Disorder

March 19, 2021

Rehan Aziz, MD.

Rehan Aziz, MD. Associate Professor of Psychiatry and Neurology, Rutgers Robert Wood Johnson Medical School. Dr. Aziz has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Previously, clinicians commonly stopped opioid agonists (methadone and buprenorphine) to simplify pain control during and after surgery. New guidance from the American Society of Addiction Medicine now suggests otherwise.

Management of Opioid Withdrawal in the Emergency Setting

March 19, 2021

Rehan Aziz, MD.

Rehan Aziz, MD. Associate Professor of Psychiatry and Neurology, Rutgers Robert Wood Johnson Medical School. Dr. Aziz has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

An emergency department visit can be a “reachable moment” for people with unhealthy opioid use. Here, we review pharmacologic and harm-reduction strategies for use in those settings—and how to advocate for your patients when consulting with emergency clinicians.

Kratom: A Primer

February 3, 2021

Alison Knopf

Alison Knopf Editor, Alcoholism & Drug Abuse Weekly Ms. Knopf has disclosed that she has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

With opioid-like properties, kratom’s recreational use is increasingly reported among those seeking pain relief or a high. This primer reviews what’s known about this unregulated substance, how to talk about it in the clinic, and early evidence on how to treat its withdrawal syndrome.

Supporting Patients With Pain and Addiction

February 3, 2021

Ajay Manhapra, MD

Ajay Manhapra, MD

Section Chief, Pain Medicine, Department of Physical Medicine & Rehabilitation Services, Hampton VA Medical Center. Assistant Professor, Departments of Physical Medicine & Rehabilitation and Psychiatry, Eastern Virginia Medical School, Norfolk, VA; Lecturer in Psychiatry, Yale School of Medicine, New Haven, CT. Dr. Manhapra has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Dr. Manhapra works with patients with disabling chronic pain, many of whom meet criteria for substance use disorders. He describes his approach to these intersecting phenomena, the biology of pain and its relationship to the reward system, and outlines an approach to improving function among patients with addiction and severe pain.

CLINICAL UPDATE

Despair, Loneliness, and Substance Use Disorders

October 21, 2020

Rehan Aziz, MD.

Rehan Aziz, MD. Associate Professor of Psychiatry and Neurology, Rutgers Robert Wood Johnson Medical School. Dr. Aziz has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Loneliness is a readily measurable phenomenon and it predicts worse outcomes in addiction treatment on the individual and population levels. What can we do in the clinic to combat loneliness and promote social cohesion?

Faith and Addiction

October 21, 2020

Jesse Koskey, MD.

Jesse Koskey, MD. Psychiatrist at Kaiser Permanente, CA. Dr. Koskey has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Faith may be a protective factor against addiction, and some widely accepted treatments use faith to build recovery capacity. This article reviews the evidence for faith-based treatment and provides suggestions for incorporating faith in the clinic.